Danielle E. Buttke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danielle E. Buttke has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Bryan S. Kaplan
Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, 1920 Dayton Avenue, Ames, IA 50010
4 shared publicationsJennifer L. Malmberg
National Wildlife Research Center, Wildlife Services, Animal and Plant Health Inspection Service, US Department of Agriculture, Fort Collins, Colorado 80521, USA
3 shared publicationsLee C. Jones
US Fish and Wildlife Service, Natural Resource Program Center, Wildlife Health, 10 East Babcock, Room 105, Bozeman, Montana 59715, USA
3 shared publicationsA. Springer Browne
United States Department of Agriculture, Center for Epidemiology and Animal Health, 2150 Centre Ave Building B, Fort Collins, CO 80524, United States
2 shared publicationsCara C. Cherry
Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30333, USA
2 shared publicationsCatherine B. Krus
Department of Clinical Sciences, College of Veterinary Medicine, Colorado State University, 300 West Drake Road, Fort Collins, CO 80526, USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 62 (2) , 464-470
Maintenance of Subclinical Mycoplasma bovis Infections in American Bison (Bison bison) in the Absence of Detectable Transmission
Mycoplasma bovis is a growing threat to American bison (Bison bison) health and restoration efforts, causing significant mortality and disease in affected bison herds. Despite this, little is known about the epidemiology or clinical course of M. bovis infection in bison. In this study, we present continued observations from a cohort of naturally infected American bison, in which maintenance of subclinical M. bovis infections was previously reported. Most (8/11) surviving previously infected animals mounted a detectable immunoglobulin G (IgG) response that waned within 6–24 mo. Two bison mounted and maintained robust IgG antibody responses throughout the study period; one of these also remained quantitative PCR and culture positive throughout the study. One animal failed to mount a detectable IgG response despite becoming infected with M. bovis during the study. Also, naïve animals (n=4) were added to the environment where positive animals were previously kept, shared a water tank with known positive animals, and were finally added to the cohort and sampled at 3-mo intervals for a 2-yr follow-up period. The four naïve animals, and a calf born to one of them, remained M. bovis negative despite commingling with known positive animals in the cohort. We discuss limitations of current antemortem test approaches and the need for more accurate testing to support healthy bison restoration and management.
- 1 April 2026
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 62 (2) , 464-470
Open AccessMaintenance of Subclinical Mycoplasma bovis Infections in American Bison (Bison bison) in the Absence of Detectable Transmission
Mycoplasma bovis is a growing threat to American bison (Bison bison) health and restoration efforts, causing significant mortality and disease in affected bison herds. Despite this, little is known about the epidemiology or clinical course of M. bovis infection in bison. In this study, we present continued observations from a cohort of naturally infected American bison, in which maintenance of subclinical M. bovis infections was previously reported. Most (8/11) surviving previously infected animals mounted a detectable immunoglobulin G (IgG) response that waned within 6–24 mo. Two bison mounted and maintained robust IgG antibody responses throughout the study period; one of these also remained quantitative PCR and culture positive throughout the study. One animal failed to mount a detectable IgG response despite becoming infected with M. bovis during the study. Also, naïve animals (n=4) were added to the environment where positive animals were previously kept, shared a water tank with known positive animals, and were finally added to the cohort and sampled at 3-mo intervals for a 2-yr follow-up period. The four naïve animals, and a calf born to one of them, remained M. bovis negative despite commingling with known positive animals in the cohort. We discuss limitations of current antemortem test approaches and the need for more accurate testing to support healthy bison restoration and management.
- 28 February 2026
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 251, 106782
Corrigendum to “Mycoplasma bovis outbreaks in United States bison (Bison bison) herds: A case-control survey” [Prev. Vet. Med. 243 (2025) 106597]
- 28 February 2026
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 251, 106782
Corrigendum to “Mycoplasma bovis outbreaks in United States bison (Bison bison) herds: A case-control survey” [Prev. Vet. Med. 243 (2025) 106597]
- Open Access
- 14 January 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Evaluation of a P48 ELISA for Mycoplasmopsis (Mycoplasma) bovis in North American bison (Bison bison): inferior performance compared to a commercially available ELISA
Background: Mycoplasmopsis (Mycoplasma) bovis is a significant pathogen in North American bison ( Bison bison ), causing severe disease with high morbidity and mortality. Effective serological diagnostics are essential for the surveillance and management of disease, yet commercially available ELISAs for M. bovis have only been developed for use in cattle and have not been validated in bison. In this study we evaluated a P48-based indirect ELISA for M. bovis detection and compared its diagnostic performance to a commercially available ELISA developed for use in cattle. Serum samples from bison were tested using both assays, and diagnostic metrics were assessed in comparison to infection status as confirmed by PCR and/or culture. Results: The commercial ELISA demonstrated superior sensitivity (77.8%) and specificity (98.0%) compared to the P48 ELISA (63.9% sensitivity, 94.9% specificity). Combining both ELISAs slightly improved sensitivity (83.3%) but did not significantly enhance overall diagnostic performance. Both the P48 and commercial ELISAs also exhibited cross-reactivity with other Mycoplasma species. Conclusions: We identify significant challenges in serological diagnostics of M. bovis in bison with implications for interpretation of previous serological studies. Future research should focus on multiple immunogenic targets to enhance sensitivity and specificity for M. bovis serological surveillance.
- 14 January 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Open AccessEvaluation of a P48 ELISA for Mycoplasmopsis (Mycoplasma) bovis in North American bison (Bison bison): inferior performance compared to a commercially available ELISA
Background: Mycoplasmopsis (Mycoplasma) bovis is a significant pathogen in North American bison ( Bison bison ), causing severe disease with high morbidity and mortality. Effective serological diagnostics are essential for the surveillance and management of disease, yet commercially available ELISAs for M. bovis have only been developed for use in cattle and have not been validated in bison. In this study we evaluated a P48-based indirect ELISA for M. bovis detection and compared its diagnostic performance to a commercially available ELISA developed for use in cattle. Serum samples from bison were tested using both assays, and diagnostic metrics were assessed in comparison to infection status as confirmed by PCR and/or culture. Results: The commercial ELISA demonstrated superior sensitivity (77.8%) and specificity (98.0%) compared to the P48 ELISA (63.9% sensitivity, 94.9% specificity). Combining both ELISAs slightly improved sensitivity (83.3%) but did not significantly enhance overall diagnostic performance. Both the P48 and commercial ELISAs also exhibited cross-reactivity with other Mycoplasma species. Conclusions: We identify significant challenges in serological diagnostics of M. bovis in bison with implications for interpretation of previous serological studies. Future research should focus on multiple immunogenic targets to enhance sensitivity and specificity for M. bovis serological surveillance.
- Open Access
- 2 January 2026
- Published by Frontiers Media SA in Frontiers in Ecology and Evolution
- Vol. 13, 1689117
Mycoplasma bovis in North American bison (Bison bison): history, advances, and challenges
North American bison ( Bison bison ) are keystone herbivores that shaped the ecology and evolution of North American prairies and peoples alike. Bison populations were pushed to near-extinction at the turn of the 20 th century. Today, bison remain highly susceptible to newly introduced pathogens to which they have not evolved immunity, and Mycoplasma bovis is a significant threat to bison health. Although M. bovis is frequently associated with multifactorial bovine respiratory disease complex in its reservoir host, domestic cattle, M. bovis is a devastating primary pathogen in bison. As a fastidious, insidious, and rapidly mutating organism that lacks a cell wall, M. bovis is difficult to diagnose in an infected animal, and the lack of bison-specific knowledge and diagnostic tools further limits options for herd managers. Here we present a review of the current state of the field of M. bovis in bison, identify gaps in our understanding of bison physiology and M. bovis ecology, and we highlight the unique evolutionary differences of bison from domestic livestock. Dedicated bison research is urgently needed to improve prevention, surveillance, response, and management of M. bovis in this iconic North American wildlife species.
- 2 January 2026
- Published by Frontiers Media SA in Frontiers in Ecology and Evolution
- Vol. 13, 1689117
Open AccessMycoplasma bovis in North American bison (Bison bison): history, advances, and challenges
North American bison ( Bison bison ) are keystone herbivores that shaped the ecology and evolution of North American prairies and peoples alike. Bison populations were pushed to near-extinction at the turn of the 20 th century. Today, bison remain highly susceptible to newly introduced pathogens to which they have not evolved immunity, and Mycoplasma bovis is a significant threat to bison health. Although M. bovis is frequently associated with multifactorial bovine respiratory disease complex in its reservoir host, domestic cattle, M. bovis is a devastating primary pathogen in bison. As a fastidious, insidious, and rapidly mutating organism that lacks a cell wall, M. bovis is difficult to diagnose in an infected animal, and the lack of bison-specific knowledge and diagnostic tools further limits options for herd managers. Here we present a review of the current state of the field of M. bovis in bison, identify gaps in our understanding of bison physiology and M. bovis ecology, and we highlight the unique evolutionary differences of bison from domestic livestock. Dedicated bison research is urgently needed to improve prevention, surveillance, response, and management of M. bovis in this iconic North American wildlife species.
- Open Access
- 5 September 2025
- Published by Elsevier in International Journal for Parasitology: Parasites and Wildlife
- Vol. 28, 101134
Nemabiome metabarcoding of wild conservation bison herds and co-grazing cattle reveals different species compositions and low-level benzimidazole resistance
- 5 September 2025
- Published by Elsevier in International Journal for Parasitology: Parasites and Wildlife
- Vol. 28, 101134
Open AccessNemabiome metabarcoding of wild conservation bison herds and co-grazing cattle reveals different species compositions and low-level benzimidazole resistance
- 1 July 2025
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 61 (3) , 563-573
MYCOPLASMA BOVIS OUTBREAK AND MAINTENANCE OF SUBCLINICAL INFECTIONS IN AN EXPOSED COHORT OF JUVENILE AMERICAN BISON (BISON BISON)
The American bison (Bison bison) is an ecologically, economically, and culturally significant species that is exceptionally vulnerable to disease caused by Mycoplasma bovis. In contrast to livestock in which M. bovis is one of many infectious agents comprising the bovine respiratory disease complex, infection in bison is characterized by severe pneumonia and potential for systemic disease in the absence of coinfecting pathogens. In bison, morbidity and mortality are highest in adult cows, whereas calves and yearlings infrequently present with clinical disease. The infection dynamics of M. bovis in young bison exposed during an outbreak have not been fully characterized. Herein, we describe a severe outbreak of M. bovis in a closed, extensively managed herd from which we established a cohort of young bison for longitudinal observation, sampling, and testing. Our findings indicate that M. bovis can colonize the nasopharynx of calves and yearlings during an outbreak, often without causing apparent clinical signs. Although some animals cleared the infection during a 12-mo follow-up study, others remained PCR and culture positive, highlighting the potential for asymptomatic carriage in bison calves as a source of subsequent outbreaks. Using a paired swabbing approach, we show that sampling the superficial nasal cavity is adequate for detection of M. bovis during an outbreak. Over time, however, deep sampling of the nasopharynx is necessary to maximize detection of subclinical infections. Uncertainty in detection using PCR on nasal swab samples can complicate herd assessments and limit the ability to fully assess risk. This study emphasizes the difficulty of identifying chronic carriers following an outbreak and underscores the need for further research to inform M. bovis management and minimize risk in the sensitive and iconic American bison.
- 1 July 2025
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 61 (3) , 563-573
MYCOPLASMA BOVIS OUTBREAK AND MAINTENANCE OF SUBCLINICAL INFECTIONS IN AN EXPOSED COHORT OF JUVENILE AMERICAN BISON (BISON BISON)
The American bison (Bison bison) is an ecologically, economically, and culturally significant species that is exceptionally vulnerable to disease caused by Mycoplasma bovis. In contrast to livestock in which M. bovis is one of many infectious agents comprising the bovine respiratory disease complex, infection in bison is characterized by severe pneumonia and potential for systemic disease in the absence of coinfecting pathogens. In bison, morbidity and mortality are highest in adult cows, whereas calves and yearlings infrequently present with clinical disease. The infection dynamics of M. bovis in young bison exposed during an outbreak have not been fully characterized. Herein, we describe a severe outbreak of M. bovis in a closed, extensively managed herd from which we established a cohort of young bison for longitudinal observation, sampling, and testing. Our findings indicate that M. bovis can colonize the nasopharynx of calves and yearlings during an outbreak, often without causing apparent clinical signs. Although some animals cleared the infection during a 12-mo follow-up study, others remained PCR and culture positive, highlighting the potential for asymptomatic carriage in bison calves as a source of subsequent outbreaks. Using a paired swabbing approach, we show that sampling the superficial nasal cavity is adequate for detection of M. bovis during an outbreak. Over time, however, deep sampling of the nasopharynx is necessary to maximize detection of subclinical infections. Uncertainty in detection using PCR on nasal swab samples can complicate herd assessments and limit the ability to fully assess risk. This study emphasizes the difficulty of identifying chronic carriers following an outbreak and underscores the need for further research to inform M. bovis management and minimize risk in the sensitive and iconic American bison.
- Open Access
- 13 June 2025
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 243, 106597
Mycoplasma bovis outbreaks in United States bison (Bison bison) herds: A case-control survey
- 13 June 2025
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 243, 106597
Open AccessMycoplasma bovis outbreaks in United States bison (Bison bison) herds: A case-control survey
- Open Access
- 12 June 2025
- Published by Oxford University Press (OUP) in BioScience
- Vol. 76 (10) , 1203-1211
Applying the resist–accept–direct (RAD) framework to wildlife health management
Wildlife diseases can have substantial impacts on wildlife populations as well as on human and domestic animal health and well-being. Although many agencies and stakeholders share a goal of supporting wildlife health, reducing wildlife disease burden is complicated by a scarcity of effective interventions for wildlife, competition for funds, and conflicting priorities. As a result, agencies are unlikely to avoid the impacts of wildlife diseases in all contexts and need to evaluate where resisting disease is most feasible and beneficial. The resist–accept–direct (RAD) framework is a tool that assists natural resource managers in exploring and communicating about management interventions, including in situations where resisting ecological changes may not be possible. In the present article, we discuss how the RAD framework could be adapted to wildlife disease contexts to address several outstanding challenges in wildlife health management.
- 12 June 2025
- Published by Oxford University Press (OUP) in BioScience
- Vol. 76 (10) , 1203-1211
Open AccessApplying the resist–accept–direct (RAD) framework to wildlife health management
Wildlife diseases can have substantial impacts on wildlife populations as well as on human and domestic animal health and well-being. Although many agencies and stakeholders share a goal of supporting wildlife health, reducing wildlife disease burden is complicated by a scarcity of effective interventions for wildlife, competition for funds, and conflicting priorities. As a result, agencies are unlikely to avoid the impacts of wildlife diseases in all contexts and need to evaluate where resisting disease is most feasible and beneficial. The resist–accept–direct (RAD) framework is a tool that assists natural resource managers in exploring and communicating about management interventions, including in situations where resisting ecological changes may not be possible. In the present article, we discuss how the RAD framework could be adapted to wildlife disease contexts to address several outstanding challenges in wildlife health management.
- Open Access
- 9 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0288812
Predicting climate-change induced heat-related illness risk in Grand Canyon National Park visitors
Background: The climate crisis is the greatest public health threat of the 21st century. Excessive heat is responsible for more deaths than any other extreme weather event, and the frequency, intensity, and duration of extreme heat events are increasing globally due to climate change. Exposure to excessive heat can result in heat related illnesses (HRIs) and long-term poor health outcomes. Physical exertion, sudden exposure to excessive heat, and the lack of physical or behavioral adaptation resources are all associated with greater HRI risk, which is expected to increase for visitors to Grand Canyon National Park (GCNP) and other public lands as climate change worsens. Objectives: Our objectives were to understand 1) the relationship between weather and HRI in GCNP visitors, 2) how future HRI rates may change, and 3) how land management agencies can update risk mitigation strategies to match changing risk and better manage an increased HRI burden. Methods: We utilized previously published data on HRI in GCNP visitors, and records of daily visitation, temperatures, and maximum and minimum daily humidity from the same study period to develop a model estimate for HRI risk. We then used future climate projections from the World Climate Research Programme’s Coupled Model Intercomparison Project phase 5 multi-model dataset to model future HRI risk under different climate scenarios. Results: The incidence of HRI was significantly associated with maximum daily temperature and minimum relative humidity, and was more common in the shoulder season months. We estimated that HRI will increase 29%-137% over 2004–2009 levels through 2100, assuming no change in visitation. Discussion: Climate change will continue to increase HRI risk for GCNP visitors and poses risks to public land managers’ mission to provide for safe recreation experiences for the benefit of this and future generations in places like GCNP. Excessive risk during the shoulder season months presents an opportunity to increase preventative search and rescue and education efforts to mitigate increased risk.
- 9 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0288812
Open AccessPredicting climate-change induced heat-related illness risk in Grand Canyon National Park visitors
Background: The climate crisis is the greatest public health threat of the 21st century. Excessive heat is responsible for more deaths than any other extreme weather event, and the frequency, intensity, and duration of extreme heat events are increasing globally due to climate change. Exposure to excessive heat can result in heat related illnesses (HRIs) and long-term poor health outcomes. Physical exertion, sudden exposure to excessive heat, and the lack of physical or behavioral adaptation resources are all associated with greater HRI risk, which is expected to increase for visitors to Grand Canyon National Park (GCNP) and other public lands as climate change worsens. Objectives: Our objectives were to understand 1) the relationship between weather and HRI in GCNP visitors, 2) how future HRI rates may change, and 3) how land management agencies can update risk mitigation strategies to match changing risk and better manage an increased HRI burden. Methods: We utilized previously published data on HRI in GCNP visitors, and records of daily visitation, temperatures, and maximum and minimum daily humidity from the same study period to develop a model estimate for HRI risk. We then used future climate projections from the World Climate Research Programme’s Coupled Model Intercomparison Project phase 5 multi-model dataset to model future HRI risk under different climate scenarios. Results: The incidence of HRI was significantly associated with maximum daily temperature and minimum relative humidity, and was more common in the shoulder season months. We estimated that HRI will increase 29%-137% over 2004–2009 levels through 2100, assuming no change in visitation. Discussion: Climate change will continue to increase HRI risk for GCNP visitors and poses risks to public land managers’ mission to provide for safe recreation experiences for the benefit of this and future generations in places like GCNP. Excessive risk during the shoulder season months presents an opportunity to increase preventative search and rescue and education efforts to mitigate increased risk.
- 1 April 2022
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 58 (2) , 465-468
Rabies as a Potential Cause of Mass Mortality Events in North American Bat Species
Rabies-association bat mortality events are rarely reported, suggesting that rabies is not a significant cause of bat mass mortality. Three bat die-offs in National Park Service units were attributed to rabies, highlighting the value of including rabies, and rabies virus strain spillover events, as a differential in mass mortality events.
- 1 April 2022
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 58 (2) , 465-468
Rabies as a Potential Cause of Mass Mortality Events in North American Bat Species
Rabies-association bat mortality events are rarely reported, suggesting that rabies is not a significant cause of bat mass mortality. Three bat die-offs in National Park Service units were attributed to rabies, highlighting the value of including rabies, and rabies virus strain spillover events, as a differential in mass mortality events.